Egypt Contraceptive Devices Market Report 2022 to 2030

Egypt Contraceptive Devices Market Analysis

$ 3999

Egypt's Contraceptive Devices Market is expected to witness growth from $36 Mn in 2022 to $75 Mn in 2030 with a CAGR of 9.50% for the forecasted year 2022-30. Egypt's contemporary contraceptive prevalence rate reached 49.4% in 2020, although there is still tremendous space for market expansion. The market is segmented by type and by gender. Some key players in this market include Eva Pharma, Delta Pharma, Amoun Pharmaceutical, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, Pregna International, and Teva Pharmaceutical.

ID: IN10EGMD005 CATEGORY: Medical Devices GEOGRAPHY: Egypt AUTHOR: Jigyasu Bhandari

Buy Now

Egypt Contraceptive Devices Healthcare Market Executive Analysis

Egypt's Contraceptive Devices Market is expected to witness growth from $36 Mn in 2022 to $75 Mn in 2030 with a CAGR of 9.50% for the forecasted year 2022-30. In Egypt, 5.2% of the overall budget, or 1.5% of GDP, went to the health sector until 2021. The proportion of healthcare expenses in the budget declined, from 4.9% in 2019 to 4.2% in 2022, the lowest percentage in the preceding five years. With 1.6% of GDP, government spending on health reached a record high. In Egypt, public health spending has risen to 3% of GDP.

In Egypt, the prevention of unplanned births is greatly aided by contraceptive methods such as intrauterine devices (IUDs), implants, and patches. This can assist people and families in making better life plans and achieving their objectives, such as finishing their schooling or starting a profession. By enabling women to spread out their pregnancies and steer clear of high-risk pregnancies, the adoption of current contraceptive techniques can aid in lowering maternal mortality rates. This can enhance results for mother and child health, lowering the likelihood of difficulties during labour, among other benefits. Some contraceptive methods, including condoms for men and women, can also aid in reducing the spread of HIV and other STDs. This can enhance sexual health outcomes and slow the transmission of STIs. Through the use of contraceptive methods, people can make more independent decisions about their bodies and lives and have more control over their reproductive health. This can be particularly significant for women living in patriarchal nations like Egypt, where cultural norms and traditional gender roles can restrict women's agency and autonomy.

Egypt Contraceptive Devices Market Analysis

Market Dynamics

Market Growth Drivers

In Egypt, there is a rising tendency to increase the number of distribution channels for contraceptive methods, including drug stores, community health workers, and portable clinics. Especially in rural and impoverished areas, this can help to enhance access to and awareness of contraceptive devices. With a high unmet need for contraception among women of reproductive age, there is a rising demand for family planning in Egypt. The country's contemporary contraceptive prevalence rate (CPR) reached 49.4% in 2020, although there is still tremendous space for market expansion. In Egypt, the market for contraceptive devices is seeing technical developments, such as the creation of novel and cutting-edge contraceptive methods that are more efficient, user-friendly, and have fewer adverse effects. This could encourage market expansion and increase demand for these devices.

Market Restraints

In Egypt, there exist societal and cultural restrictions on the use of contraceptive methods, especially in conservative and religious areas. The use of contraceptive methods may also be restricted by misconceptions regarding their efficacy and safety. In Egypt, particularly in remote and impoverished areas, access to healthcare can be restricted. Individuals may find it challenging to obtain contraceptives and other reproductive health treatments as a result. Manufacturers may find it difficult to negotiate Egypt's complex regulatory environment for contraceptive devices. Delays in product registration and clearance may result from this, which would reduce the market's access to fresh, cutting-edge items.

Competitive Landscape

Key Players

Eva Pharma (EG)
Delta Pharma (EG)
Amoun Pharmaceutical (EG)
Mylan Laboratories
Church & Dwight
CooperSurgical
Pfizer
Pregna International
Teva Pharmaceutical

Healthcare Policies and Regulatory Landscape

The Ministry of Health and Population, which is in charge of guaranteeing the safety and effectiveness of contraceptive devices, is in charge of overseeing healthcare policies and the regulatory environment for contraceptive devices in Egypt. Before being sold in Egypt, all medical equipment, including contraceptive devices, must be registered with the Ministry of Health and Population. This procedure, which requires manufacturers to present proof of the device's reliability, effectiveness, and safety, can take a long time and be expensive. The Ministry of Health and Population controls the importation of medical devices, including contraceptive devices. The gadget must be imported with a registration certificate, and importers must make sure it complies with all applicable quality standards. The Ministry of Health and Population regulates the advertising of contraceptive devices and sets standards for the veracity and accuracy of claims made in such advertisements.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Contraceptive Devices Market Segmentation

By Type (Revenue, USD Billion):

A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use, women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS, per the World Health Organization Updates in November 2020. To a lesser extent, they also protect against genital herpes, human papillomavirus (HPV), and syphilis. Hence, the other reasons that aid the growth of the contraception devices market are the rising occurrence of STDs and the substantial increase in the population

Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
Intra Uterine Devices (IUD)
Other Devices

By Gender (Revenue, USD Billion):

Based on Gender the contraceptive devices market is segmented into male and female.

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.